|
|||||
|
|
A phase I study of PF-04929113 (SNX-5422), an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumor malignancies and lymphomas |
|
| Authors: | Rajan Arun Kelly Ronan J Trepel Jane B Kim Yeong Sang Alarcon Sylvia V Kummar Shivaani Gutierrez Martin Crandon Sonja Zein Wadih M Jain Lokesh Mannargudi Baskar Figg William D Houk Brett E Shnaidman Michael Brega Nicoletta Giaccone Giuseppe |
| Affiliation: | Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA. |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |